Doctor profile · Federal record

Dr. Muhammad Tarakji, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Albuquerque, NM

  • NPI 1750497863
  • Accepts Medicare
  • MIPS 93.3 / 100 · 2023
  • 26 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
715 Dr Martin Luther King JR Ave Ne Ste 102
Albuquerque, NM 871023666
(505) 727-3040
fax (505) 727-9590
Mailing address
Po Box 840063
Dallas, TX 752840063

Credentials & registration

NPPES · NUCC
NPI registered
August 2006 — 20 yrs on file
Profile last updated
March 11, 2022
Year of graduation
2000 — 26 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
New Mexico #MD2011-0601

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1750497863. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
19,771
Distinct HCPCS
10
Medicare allowed
$240,519
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 12,240 21 $1
J1453 Injection, fosaprepitant, 1 mg 3,900 11 $0
J1100 Injection, dexamethasone sodium phosphate, 1 mg 922 28 $0
J2469 Injection, palonosetron hcl, 25 mcg 530 21 $1
99215 Established patient office or other outpatient visit, 40-54 minutes 528 149 $168
96413 Administration of chemotherapy into vein, 1 hour or less 211 54 $120
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes 193 63 $113
99214 Established patient office or other outpatient visit, 30-39 minutes 183 128 $120
J9217 Leuprolide acetate (for depot suspension), 7.5 mg 146 22 $172
96375 Injection of additional new drug or substance into vein 125 28 $14

In context: peer comparison

Among 14 peers in this city , average services per provider: 745. This provider delivers 27× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,950
Transactions
55
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals LP 5 $688.76
Daiichi Sankyo Inc. 2 $554.21
Janssen Biotech, Inc. 5 $192.80
Novartis Pharmaceuticals Corporation 10 $170.05
Gilead Sciences, Inc. 6 $129.98
E.R. Squibb & Sons, L.L.C. 5 $91.26
GENZYME CORPORATION 3 $76.53
Regeneron Healthcare Solutions, Inc. 3 $69.28
Genentech USA, Inc. 2 $62.35
ABBVIE INC. 3 $60.31
PFIZER INC. 3 $58.39
Amgen Inc. 2 $51.34
Eisai Inc. 2 $46.44
Astellas Pharma US Inc 2 $44.24
Celgene Corporation 2 $43.89

By nature of payment

Food and Beverage
$1,771
Consulting Fee
$1,050
Education
$129

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
602
Patients
131
Total drug cost
$807,340
Drug Type Claims Patients Total cost
Letrozole Generic 150 44 $4,356
Eliquis (Apixaban) Brand 81 15 $53,491
Gabapentin Generic 61 13 $575
Ondansetron Hcl Generic 48 22 $1,011
Hydroxyurea Generic 35 0 $1,230
Anastrozole Generic 30 0 $481
Prochlorperazine Maleate Generic 28 17 $496
Duloxetine Hcl Generic 27 0 $331
Xtandi (Enzalutamide) Brand 24 0 $335,557
Kisqali (Ribociclib Succinate) Brand 22 0 $387,703

Frequently asked questions

Auto-generated from federal data
What is Dr. Muhammad Tarakji's medical specialty?
Dr. Muhammad Tarakji practices Hematology & Oncology Physician in Albuquerque, NM.
Where does Dr. Muhammad Tarakji practice?
Dr. Muhammad Tarakji practices at 715 Dr Martin Luther King JR Ave Ne Ste 102, Albuquerque, NM 871023666. Office phone: 5057273040.
What is Dr. Muhammad Tarakji's NPI?
Dr. Muhammad Tarakji's National Provider Identifier (NPI) is 1750497863, issued by NPPES.
Does Dr. Muhammad Tarakji accept Medicare assignment?
Yes. Dr. Muhammad Tarakji accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Muhammad Tarakji commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, dexamethasone sodium phosphate, 1 mg (HCPCS J1100). Source: CMS Medicare Physician & Other Practitioners file.